Please assess the completion status of the following clinical trial:

Trial Title: To Evaluate the Efficacy and Safety of DW1903 in Acute and Chronic Gastritis Patient

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients who were diagnosed with acute or chronic gastritis in a gastroscopy performed within 7 days prior to administration of this trial.~* At least one or more erosions have been identified on gastroscopy.~* Patients who decided to voluntarily participate in this trial and agreed in writing.~Exclusion Criteria:~* Patients who can not undergo gastroscopy~* Peptic ulcer (except scarring) and reflux esophagitis~* Patients who have had gastric acid suppression surgery or stomach/esophagus surgery (except for simple perforation surgery and appendectomy)~* Patients with a history of gastrointestinal malignancies~* Zollinger-Ellison syndrome patients~* Patient with spontaneous coagulation disorder~* Patients with an allergic or hypersensitive response to a study drug~* Patients with a potential pregnancy.~* Patients who had clinically significant abnormalities in the screening test.~* Pregnant and lactating women~* Those currently taking other study drugs~* patients who were judged to be ineligible for the trial by the principle investigator and the person in charge.

- Gender: ALL
- Minimum Age: 19 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- DW1903(Test) (Type: EXPERIMENTAL): once a day, q.d. PO / DW1903 + Placebo of DW1903-R1
- DW1903-R1(Reference) (Type: ACTIVE_COMPARATOR): once a day, q.d. PO / Placebo of DW1903 + DW1903-R1

Based on this trial design, predict the completion outcome and termination type (if applicable).